Patrick Blaney

15PUBLICATIONS
119CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyMedical mycologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 12, 2026
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

|Feb 27, 2026
Study of NSD2 using a dTAG system reveals its molecular mechanism and oncogenic implications in t(4;14) multiple myeloma.

Yubao Wang, Sanxiong Liu, Hussein Ghamlouch

|Oct 08, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu

|Aug 20, 2025
Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Francesco Maura, Marcella Kaddoura, Alexandra M Poos

|May 07, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.

Dylan C Gagler, Hussein Ghamlouch, Di Zhang

|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.

Travis S Johnson, Parvathi Sudha, Enze Liu

Pageof 3

Frequent Collaborators

9 joint publications

Ola Landgren

9 joint publications

Gareth Morgan

9 joint publications

Francesco Maura

7 joint publications

Kylee Maclachlan